Cosentyx (secukinumab) - Novartis
Cosentyx: Data from P2 ARROW trial (NCT03553823) for plaque psoriasis at the end of 2019 (Novartis) - May 25, 2019 - Investor Event 
P2 data
https://www.novartis.com/sites/www.novartis.com/files/2019-05-meet-novartis-management-presentation.pdf
 
May 25, 2019
 
 
270ea494-360e-410b-be2f-c2021739a8d4.jpg